All news

Amgen Inc. $AMGN Stock Sold by First Bank & Trust

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

First Bank & Trust reduced its stake in Amgen Inc. by 22.5% in the third quarter, selling 2,479 shares. Despite this, institutional investors collectively own 76.5% of Amgen's stock, and analysts maintain a "Hold" rating with an average price target of $387.93. Amgen recently reported strong quarterly earnings and revenue, surpassing expectations.

Read original source

AMGN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.